Summit Therapeutics Inc. (SMMT)
Nasdaq • SMMT • US86627T1088
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 22, 2026, ORTEX estimated 27.2% of free float sold short, 5.9 days to cover, cost to borrow 0.69%. Sign up for live short interest data.
Market Cap
13.1b USD | # 1348 in US
Volume
6.23m shares | 97.72m USD
Shares Outstanding
799.76m
Free Float Shares
19.29% | 154.3m
